Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

James Niedel


  • Director at Chimerix Inc (CMRX), 2017-06-29
  • Large Shareholder at Versartis Inc. (VSAR), 2014-10-01
  • Large Shareholder at Concert Pharmaceuticals Inc. (CNCE), 2014-02-21
  • Other at Oxford Immunotec Global Plc (OXFD), 2013-12-03
  • Large Shareholder at Mei Pharma Inc. (MEIP), 2013-11-25
  • Other at Relypsa Inc (RLYP), 2013-11-21
  • Large Shareholder at World Heart Corp (WHRT), 2012-08-06
  • Large Shareholder at Durata Therapeutics Inc. (DRTX), 2012-07-26
  • Other at Icagen Inc (ICGN), 2011-07-29
  • Other at Transcept Pharmaceuticals Inc (TSPT), 2011-07-20
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CMRX $29.58 328,680 Director 1,046,082 2014-09-11 Filing
CMRX $30.03 97,129 Director 1,374,762 2014-09-10 Filing
CMRX $29.54 347,188 Director 1,070,133 2014-09-10 Filing
CMRX $28.54 51,100 Director 1,417,321 2014-09-09 Filing
CMRX $29.67 58,531 Director 1,267,542 2014-09-09 Filing